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Abstract: The study of DNA to predict externally visible characteristics (EVCs) and the biogeographical
ancestry (BGA) from unknown samples is gaining relevance in forensic genetics. Technical
developments in Massively Parallel Sequencing (MPS) enable the simultaneous analysis of hundreds of
DNA markers, which improves successful Forensic DNA Phenotyping (FDP). The EU-funded VISAGE
(VISible Attributes through GEnomics) Consortium has developed various targeted MPS-based lab
tools to apply FDP in routine forensic analyses. Here, we present an evaluation of the VISAGE Basic
tool for appearance and ancestry prediction based on PowerSeq chemistry (Promega) on a MiSeq FGx
System (Illumina). The panel consists of 153 single nucleotide polymorphisms (SNPs) that provide
information about EVCs (41 SNPs for eye, hair and skin color from HIrisPlex-S) and continental BGA
(115 SNPs; three overlap with the EVCs SNP set). The assay was evaluated for sensitivity, repeatability
and genotyping concordance, as well as its performance with casework-type samples. This targeted
MPS assay provided complete genotypes at all 153 SNPs down to 125 pg of input DNA and 99.67%
correct genotypes at 50 pg. It was robust in terms of repeatability and concordance and provided
useful results with casework-type samples. The results suggest that this MPS assay is a useful tool
for basic appearance and ancestry prediction in forensic genetics for users interested in applying
PowerSeq chemistry and MiSeq for this purpose.
Keywords: forensic DNA phenotyping; appearance; ancestry; BGA; HIrisPlex-S; EVC prediction;
phenotype prediction; DNA phenotyping; PowerSeq; VISAGE
1. Introduction
Forensic DNA Phenotyping (FDP) involves the prediction of the physical appearance through
determining externally visible characteristics (EVCs) and the biogeographic ancestry (BGA) from
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DNA [1–3]. FDP can provide investigative leads, when standard DNA identification is not possible,
for example, due to the lack of a suspect’s reference sample or a lack of matches in National DNA
Databases [3,4]. Recent studies focused on fine-tuning the selection of DNA markers to predict physical
appearance, e.g., [5–11]. The most successful studies developed models for eye, hair and skin color
with promising prediction performance analyzing only a few dozen single nucleotide polymorphisms
(SNPs) [12–14]. It has been demonstrated that the analysis of nuclear SNPs also aids the estimation
of the biogeographical ancestry (BGA) by using at least thirty or more SNPs to obtain reliable
results [15–19]. Targeted Massively Parallel Sequencing (MPS) technologies enable the simultaneous
amplification of hundreds of DNA markers at low DNA input levels thus providing sensitive tools
that keep sample consumption low, which has started to be applied for forensic purposes including
appearance and/or ancestry prediction from DNA, e.g., [20–22]. The need for combining more
and more SNPs for combined appearance and ancestry prediction and the suitability of targeted
MPS has triggered the development of a panel consisting of 153 markers for predicting appearance
and ancestry in the framework of the VISAGE (VISible Attributes through GEnomics) Consortium
(http://www.visage-h2020.eu/). These markers had recently been implemented into a combined MPS
tool based on Ion AmpliSeq (for Thermo Fisher platforms), a chemistry of Thermo Fisher Scientific for
custom amplicon design [23]. This study presents experimental results on the evaluation of this panel
based on the PowerSeq chemistry analyzed on a MiSeq FGx System (Illumina). A series of test were
conducted, including sensitivity, repeatability, concordance and analysis of casework “mock” samples.
2. Materials and Methods
2.1. Samples and Experimental Design
The 2800 M Control DNA (Promega) was used for sensitivity and repeatability tests. DNA extracts
provided in the course of the GEDNAP (German DNA Profiling Group; https://www.gednap.org/de/)
proficiency tests were used as casework-type samples, and Coriell samples with known genotypes
were analyzed for concordance experiments.
The sensitivity of the assay was tested by a serial dilution of 2800 M Control DNA from 1 ng to
10 pg in duplicates. Repeatability was tested analyzing optimum DNA input triplicates of 2800 M
at 0.5 and 1 ng. For this purpose, one extra replicate of each DNA amount was added to the duplicates
used for the sensitivity test. Five DNA extracts from GEDNAP proficiency tests (42-S3, 44-S3, 45-S2,
49-S4 and 53-S1) quantified via real-time qPCR [24] were analyzed using the recommended DNA
input of 0.5 ng. Concordance was evaluated using four Coriell samples that have known genotypes
at 0.5 ng of DNA input. The genotypes of these samples are published in the genetic databases of
the 1000 Genomes Project ([25,26]; samples NA06994, NA07000 and NA18498) and the Simons Genome
Diversity Project (SGDP) ([27]; sample NA11200). Additionally, one non-template control (NTC)
sample was used. The 24 samples of this study were sequenced together in one run.
2.2. VISAGE Basic Tool for Predicting Appearance and Ancestry Using PowerSeq Chemistry
The VISAGE Basic Tool for predicting appearance and ancestry (BT A&A) was developed by
the VISAGE Consortium and has recently been implemented using AmpliSeq [23]. It consists of 153
SNPs, 41 of which represent the HIrisPlex-S panel to predict eye, hair and skin color [5,12–14] and 115
forming the continental BGA informative panel (3 overlapping markers in both panels). In this study
we implemented the BT A&A provided using PowerSeq chemistry (Promega, Madison, WI, USA)
and MiSeq, which we refer to here as VISAGE BT A&A (PSeq).
2.3. Library Preparation and Sequencing
All samples were analyzed following the manufacturer’s recommendations [28]. A first
amplification PCR was conducted including 5 µL of PowerSeq 5X Master Mix (Promega, Madison,
WI, USA), 5 µL of VISAGE primer mix 5X (Promega, Madison, WI, USA), template DNA and distilled
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water up to the total volume of 25 µL. PCR was conducted on an Applied Biosystems GeneAmp PCR
System 9700 (Thermo Fisher Scientific, Waltham, MA, USA) and the thermal cycling conditions were
1 min at 96 ◦C followed by 30 cycles of amplification with 10 s at 94 ◦C, 1 min at 60 ◦C and 30 s at 72 ◦C,
to finish with a final extension step of 10 min at 60 ◦C.
The amplification products were purified with the ProNex Size-Selective Purification System
(Promega, Madison, WI, USA) following the manufacturer’s instructions [28,29]. This was conducted
adding 5 µL of 1080 µg/mL Proteinase K (Promega, Madison, WI, USA) and 105 µL of ProNex Chemistry
(Promega, Madison, WI, USA) to each 25 µL of amplification product and performing two washing
steps prior to the purified product elution. The KAPA Hyper Prep Kit (Kapa Biosystems, Roche
Sequencing, Wilmington, MA, USA) was used for library preparation. The end repair and A-tailing
reaction was conducted prior to the adapter ligation step of the Illumina TruSeq Index adapters
(Illumina, San Diego, CA, USA) as indicated by the manufacturer [28,30]. The libraries were purified
with the ProNex Size-Selective Purification System (Promega, Madison, WI, USA). This was conducted
by adding 220 µL of ProNex Chemistry (Promega, Madison, WI, USA) to 110 µL of each library,
followed by two washing steps and the elution of the purified libraries.
The purified libraries were quantified with the PowerSeq Quant MS System (Promega, Madison,
WI, USA) following the manufacturers’ instructions [31]. Libraries were diluted to 4 nM, equally
pooled, denatured with 0.2N NaOH and diluted to 20 pM with HT1 buffer (Illumina, San Diego,
CA, USA). The final sequencing mix was prepared with 300 µL of HT1 buffer (Illumina, San Diego,
CA, USA), 255 µL of pooled 20 pM denatured libraries and 45 µL of 20 pM denatured PhiX Control
(Illumina, San Diego, CA, USA). Sequencing of the 24 libraries of this study was performed in one flow
cell, on a MiSeq FGx with 2 × 150 cycles and the MiSeq Reagent kit V3 (Illumina, San Diego, CA, USA).
2.4. Data Processing
Sequences were aligned to the human genome (hg19) using the BWA-MEM algorithm [32].
Data manipulation, and BAM and BAI creation were performed using SAMtools [33] and PICARD
tools. Data extraction and variant calling were performed with GATK [34,35]. The interpretation
threshold for each allele was set at 20% of the total reads obtained for that locus. Sequencing data of
each locus were also visualized with Integrative Genomics Viewer (IGV) v2.6.3 [36]. Microsoft Excel
and RStudio v1.2.1335 [37,38] were used for data processing and statistical analyses.
3. Results and Discussion
3.1. Negative Control
The baseline noise produced with the VISAGE BT A&A (PSeq) was investigated by analyzing
the NTC sample. As a result of this analysis, a total of 1502 reads were obtained in 116 SNPs (75.8% of
the SNPs included in the assay) with a mean read depth per marker of 9.82 (±49.81). Only in three
of the SNPs were more than 25 reads observed, two of which (rs1040934 and rs1426657) showed
more than 100 reads (248 and 566 reads, respectively). Nevertheless, the mean read depth per marker
obtained for the NTC was 128 times lower than the value observed for samples with 10 pg of DNA,
the lowest input amount tested here. Comparable values for NTC samples have been seen in similar
studies [39–41].
3.2. Sensitivity
Decreasing amounts of 2800 M Control DNA (Promega), from 1 ng to 10 pg, were used as
template DNA to test the sensitivity of the VISAGE BT A&A (PSeq). In the absence of the “true”
genotypes we assumed the correct calls based on the consensus of all 2800 M analyses. The correct
genotype of the complete set of 153 SNPs was obtained in all the replicates down to 125 pg input DNA
(Figure 1a). Replicates with 50 pg produced 99.67% of correct genotypes with only one allele drop-out
in one of the replicates. For the lowest amount of DNA template tested (10 pg) the number of correct
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genotypes dropped to 89.22% due to rising numbers of allele and locus drop-out in both replicates
and the appearance of one allele drop-in. The effect of decreasing DNA amount is more evident in
the number of sequencing reads with mean read depths per marker from 5809 ± 3572 reads at 1 ng to
1254 ± 1111 reads at 10 pg (Figure 1b).
Nonetheless, we did not observe a linear correlation between the allele drop-out and the number of
reads obtained for the affected markers. A third of the loci with drop-out in replicates of 10 pg yielded
more than 900 reads, while 14.7% of correctly genotyped loci had less than 300 reads. This points to
unbalanced allele amplification during PCR, probably due to the low amount of template DNA [42,43].
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Figure 1. Results obtained ith the ISible ttributes through Eno ics ( IS E) Basic Tool for
predicting appearance and ancestry (VISAGE BT A&A) (PSeq) assay for sensitivity and repeatability
tests. (a) ean percentage of correct genotypes and incorrect genotypes (drop-out, drop-in and no calls)
obtained in the sensitivity test from the dilution series of 2800 M Control DNA (1 ng–10 pg) analyzed
in duplicates. (b) Mean number of reads yielded per marker for each dilution step. (c) Average read
depth per marker obtained in each replicate of 1 ng and 0.5 ng used for repeatability test. p-values of
comparisons between replicates for Wilcoxon test are shown. (d) Mean normalized read depth per
marker of 1 ng versus 0.5 ng replicates.
3.3. Repeatability
Three replicates of 1 and 0.5 ng of template DNA were analyzed to assess the repeatability of
the VISAGE BT A&A (PSeq) assay. The average total number of reads showed a reduction from
1 ng replicates (840,590 reads) to 0.5 ng replicates (729,618 reads), with a noticeably wider standard
deviation (SD) in 1 ng replicates (±85,890 reads) than in 0.5 ng replicates (±31,202 reads), albeit not
statistically significant. A Kruskal-Wallis test showed that there were significant differences between
the average reads per marker yielded by 1 ng replicates (p < 0.05), but no significant differences among
the 0.5 replicates (Figure 1c). A Wilcoxon test revealed that the difference between 1 ng replicates
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was due to the third replicate, which had significantly lower mean reads per marker than the others.
This difference may be due to amplification and preparation of the libraries of the third replicates,
which were performed on a different day. However, the observed differences could also represent
normal variation of the assay.
Normalized read depth per marker (calculated as number of target reads per marker/total number
of reads in a sample) was analyzed in the replicates of both DNA amounts. The comparison of
the mean normalized read depth between 1 ng and 0.5 ng showed no clear difference between DNA
inputs (Figure 1d) and Kruskal–Wallis test confirmed the absence of significant differences. The mean
normalized read depth was 0.00654, and only 31 SNPs (20.26%) performed below 0.004 at both amounts
of DNA. This shows that, even if the amount of input DNA had an impact on the total reads, the read
distribution between markers stayed stable. Thus, the VISAGE BT A&A (PSeq) is a robust assay for
input DNA of 1 and 0.5 ng, the latter being the optimum amount recommended by the manufacturer.
3.4. Locus, Allele Balance and Base Misincorporation Rate
Replicates of 0.5 ng, defined as an optimum amount of input DNA recommended by Promega,
were used to assess the general performance of the VISAGE BT A&A (PSeq) assay for the analysis of
diverse sequencing parameters. The performance of loci amplification and sequencing was evaluated
by comparing the read depth obtained for every locus. Figure 2a shows the distribution of locus
balance, calculated as the ratio between the reads obtained for each locus and the average number of
reads per locus [44]. Most of the loci were well balanced, with values close to 1 (75.2%). Only 11 loci
(7.2%) showed more than double the average number of reads per locus of the whole panel, and 27 loci
(17.6%) performed below half of the average of reads per locus.
For heterozygote genotypes (40 SNPs) observed with the analyzed DNA samples, the allele read
frequency was estimated as the number of reads obtained for the reference allele (ref) divided by
the sum of reads for the reference and the alternative allele (ref + alt). Every heterozygote locus
presented well balanced alleles with mean read frequency between 0.4 and 0.6, the commonly applied
lower and upper thresholds [45–47], respectively (Figure 2b). Moreover, 75% of these loci showed
an average value in the range of 0.5 ± 0.03. Only six loci had an allele read frequency in one of
the replicates that transgressed the above thresholds for heterozygotes, three of them exceeding
0.6 (rs10483251, rs2503770 and rs7570971) and the remaining three below 0.4 (rs2337024, rs345769
and rs4792928). Allele read frequency was also estimated for the remaining amounts of input DNA of
the dilution series (Supplementary Figure S1). The first markers out of the threshold range appeared
at 0.125 ng, showing that heterozygote SNPs remain well balanced even at low DNA inputs.
The accuracy of the VISAGE BT A&A (PSeq) assay to detect the correct nucleotide at the position
of the SNPs of interest was also studied by calculating base misincorporation percentages [45]. Specific
base misincorporation (SBM) was inferred from loci with homozygote genotypes, where erroneously
incorporated nucleotides matching the possible alternative allele can be observed. Non-specific
base misincorporation (NSM), produced by the incorporation of nucleotides different to those of
the possible alleles, was calculated from every SNP. Figure 2c shows the distribution of the mean
misincorporation percentage of each SNP. The average total misincorporation percentage of the VISAGE
BT A&A (PSeq) was of 0.14% per SNP, with 0.09% of SBM and 0.05% of NSM. Six loci were free of
any type of misincorporation. In total, 31.4% of the markers, presented a misincorporation percentage
higher than the average, however, only six loci were over 0.3%. SNP rs1393350 showed the highest
misincorporation rate observed, 0.54% (0.50% SBM and 0.04% NSM). This was produced by one of
the replicates that had 1.4% of alternative allele (adenine) reads for this SNP, while it stayed below
0.07% in the remaining replicates. The visual examination revealed that this misincorporation could be
due to the presence of a small polynucleotide tract of three adenines located downstream of the SNP
(Supplementary Figure S2). This poly-A tract may mislead the polymerase, incorporating an adenine
instead of the real nucleotide of the SNP. Nevertheless, as the result of the three replicates showed,
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the misincorporation observed in this SNP is a sporadic event, due to a stochastic effect not associated
with the VISAGE BT A&A (PSeq) assay.Genes 2020, 11, x FOR PEER REVIEW 6 of 13 
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3.5. Casework “Mock” Samples
The application of the VISAGE BT A&A (PSeq) assay to five casework-type DNA samples from
GEDNAP resulted in 764 genotype calls with only one locus drop-out (no call) observed in one of
the samples. This “mock” sample, 44-S3, was also the one with the highest nu ber of markers below
200 reads, 6.54% (10 SNPs), even though it ranked second by number of total reads (Table 1).
These casework-type samples showed mean reads per marker values similar to those obtained
for the replicates of 0.05 ng of control DNA analyzed for the sensitivity test, which had 10-fold less
template DNA. This may be due to the nature of the DNA extracted from the casework-type samples,
which generally had undergone degradation, and to the long time that some samples were stored in
freezers. In this sense, these results were in agreement with previous studies where the SNP genotyping
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results from artificially degraded samples were comparable to the results obtained from non-degraded
samples with much lower DNA amounts, depending on the level of degradation [39,48].
Table 1. Summary statistics of number of reads obtained with the VISAGE BT A&A (PSeq) assay
for casework-type samples. “Mean per SNP” indicates the average read depth per single nucleotide
polymorphism (SNP) and “SD per SNP” is the standard deviation.
Sample 42-S3 44-S3 45-S2 49-S4 53-S1
Total reads 329,220 406,615 492,074 361,511 260,588
Mean per SNP 2151 2657 3216 2362 1703
SD per SNP 1351 2384 2104 1491 1202
SNPs with < 200 reads 2 11 2 3 9
3.6. Concordance
Genotyping concordance of the results obtained with the VISAGE BT A&A (PSeq) assay was
tested analyzing four Coriell DNA samples with known genotypes that are published in databases
of 1000 genomes [25,26] and SGDP [27]. All the SNPs included in BT A&A (PSeq) provided a full
genotype in all four samples. Sample NA11200 lacked information for 3 SNPs in the database. From
the 609 genotypes compared to the published data to check the concordance and genotyping accuracy
of this panel, only one allele drop-out was observed (99.84% of concordance). This discrepancy
was found in sample NA18498 for rs2789823, which should be heterozygous (AG), but resulted in
a homozygous genotype (GG) with this panel. A visual examination of the sequence did not reveal
ambiguities that could explain this result (Supplementary Figure S3). The flanking sequence of this
sample appears to be free of any variation that could affect the correct hybridization of the primers.
Thus, the discrepancy may be due to the sample itself. This was also observed in a previous analysis
of an aliquot of the same sample performed with a different assay for VISAGE BT A&A based
on AmpliSeq chemistry and using Ion Torrent S5 as MPS platform [23]. Notably, the VISAGE BT
A&A (Amp) assay, which used independently designed primers, different amplification chemistry,
different MPS chemistry and different MPS technology, obtained the same homozygous GG genotype
at rs2789823 for sample NA18498 as observed here with the VISAGE BT A&A (PSeq) assay, reinforcing
the inference that the discrepancy could be due to the sample itself. This is not unusual in DNA
samples extracted from cell lines that are the product of subsequent culturing, which could introduce
some genotype shift [49,50]. Nevertheless, in a new 1000 Genome high-coverage dataset produced
at the New York Genome Center [25], sample NA18498 has the homozygous GG genotype at rs2789823.
Hence, the heterozygous AG genotype observed at the 1000 Genomes Phase 3 database [26] could be
erroneous and instead the genotype obtained with this VISAGE BT A&A (PSeq) assay would be correct.
4. Conclusions
This study describes the evaluation of the VISAGE BT A&A (PSeq) assay that includes 153 DNA
markers for simultaneous eye, hair, and skin color as well as continental BGA prediction. This assay
has demonstrated it produces reliable and concordant results when control DNA and Coriell samples
are analyzed using 0.5 ng. The VISAGE BT A&A (PSeq) assay also gave complete genotypes at all
SNPs down to 125 pg, and 99.67% of the markers were correctly genotyped with 50 pg, confirming its
suitability for forensic sample amounts. This VISAGE BT A&A (PSeq) assay provides well-balanced
results in most of the markers. It also presented very low baseline noise and low misincorporation in
the majority of the SNPs. The analysis of casework-type samples shows promising results and suggests
that this tool can be usefully applied to forensic genetics. This study expands the applicability of
the VISAGE Basic Tool for Appearance and Ancestry to both forensically used MPS platforms, the Ion
S5 [23] and the Illumina Miseq FGx.
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Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4425/11/6/708/s1,
Figure S1: Distribution of the allele read frequency of heterozygote loci of every 2800 M Control DNA dilution.
A continuous line marks the expected optimum (0.5) while the dotted lines indicate the lower and upper thresholds
(0.4 and 0.6, respectively). (a) Allele read frequency of replicates with 1 ng DNA. (b) Allele read frequency of
replicates with 0.25 ng DNA. (c) Allele read frequency of replicates with 0.125 ng DNA. (d) Allele read frequency of
replicates with 0.05 ng DNA. (e) Allele read frequency of replicates with 0.01 ng DNA, Figure S2: Visualization of
sequence alignment of the three replicates of 0.5 ng for rs1393350 with IGV from results obtained with the VISAGE
BT A&A (PSeq) assay, Figure S3: Visualization of sequence alignment of sample NA18498 for rs2789823 with IGV
from results obtained with the VISAGE BT A&A (PSeq) assay.
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Centres and investigators of the VISible Attributes through GEnomics (VISAGE) Consortium
Website: http://www.visage-h2020.eu/
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Vivian Kalamara, Arwin Ralf, Athina Vidaki
• Jagiellonian University, Krakow, Poland: Wojciech Branicki, Ewelina Pos´piech,
Aleksandra Pisarek
• Universidade de Santiago de Compostela, Santiago de Compostela, Spain : Ángel Carracedo,
Maria Victoria Lareu, Christopher Phillips, Ana Freire-Aradas, Ana Mosquera-Miguel, María de
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• Medizinische Universität Innsbruck, Innsbruck, Austria: Walther Parson, Catarina Xavier,
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